ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
169 employees · est. 2000 · Irvine, United States
Visiox Pharmaceuticals
Advancing the Standard of Care in Ophthalmics
1 employees · est. 2022 · Columbus, United States
ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) is the older company (2000 vs 2022); ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) is the larger of the two.
Side-by-Side Comparison
| Metric | ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) | Visiox Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2000 older | 2022 |
| Headquarters | ||
| Headquarters | Irvine, United States | Columbus, United States |
| Employees | ||
| Employees | 169 larger | 1 |
| Industry | ||
| Industry | Fashion, Health Care, Pharmaceutical | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Debt Financing | Seed |
| Total Funding | ||
| Total Funding | Not tracked yet | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | Not tracked yet |
| Services | ||
| Services | Manufacturing and Distribution of Contact Lenses, Development of Ophthalmic Pharmaceuticals, Retail of Eye Care Solutions, Supply of Lens Care Products, Distribution of Diagnostic Tools for Eye Health, Provision of Surgical Eye Care Solutions, Investments in Eye Health Research and Innovation | development of branded pharmaceuticals, cutting edge ophthalmic innovation, glaucoma treatment solutions, post-surgical pain management, therapeutic product pipeline |
| Target Customers | ||
| Target Customers | Eye Care Professionals, Patients with Eye Health Needs, Healthcare Providers, Retailers of Eye Care Products, Optometrists, Ophthalmologists | patients with glaucoma, post-surgical ophthalmic patients, healthcare professionals, medical and pharmaceutical partners |
| Taxonomy | ||
| Taxonomy | Not tracked yet | Biopharmaceuticals, Ophthalmic Therapeutics, Ocular Hypertension, Open Angle Glaucoma, Post-Surgical Inflammation, Extended Release Technology, Eye Care, Ophthalmology, Brimonidine Development, Difluprednate Formulation, Therapeutic Candidates, Patient Satisfaction, Physician Collaboration, Proprietary Technology, Innovative Treatment Options |
| Website | ||
| Website | bausch.com | visioxpharma.com |
About ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)
ISTA Pharmaceuticals, founded in 2000, emerged as a dynamic specialty pharmaceutical enterprise in the United States, with a focus on eye care and allergy treatments. It gained recognition as the fourth largest branded prescription eye care business in its market, substantiated by a robust U.S. sale...
About Visiox Pharmaceuticals
Visiox Pharmaceuticals, founded in 2022, is a dynamic entity in the biopharma sector, specifically targeting advancements in ophthalmics. With its slogan, "Advancing the Standard of Care in Ophthalmics," the company aims to disrupt and improve current market offerings through innovative therapeutic...
We will tell you when either one moves
BounceWatch watches ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) and Visiox Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ISTA Pharmaceuticals (... and Visiox Pharmaceuticals — by email.
Frequently Asked Questions
Compare ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) on 31 Mar 2026, and Visiox Pharmaceuticals on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.